Literature DB >> 17680360

Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.

César A Ribeiro1, Angela M Sgaravatti, Rafael B Rosa, Patrícia F Schuck, Vanessa Grando, Anna L Schmidt, Gustavo C Ferreira, Marcos L S Perry, Carlos S Dutra-Filho, Moacir Wajner.   

Abstract

In the present work we investigated the in vitro effect of the branched-chain amino acids (BCAA) accumulating in maple syrup urine disease (MSUD) on some parameters of energy metabolism in cerebral cortex of rats. 14CO2 production from [1-14C]acetate, [1-5-14C]citrate and [U-14C]glucose, as well as glucose uptake by the brain were evaluated by incubating cortical prisms from 30-day-old rats in the absence (controls) or presence of leucine (Leu), valine (Val) or isoleucine (Ile). All amino acids significantly reduced 14CO2 production by around 20-55%, in contrast to glucose utilization, which was significantly increased by up to 90%. Furthermore, Leu significantly inhibited the activity of the respiratory chain complex IV, whereas Val and Ile markedly inhibited complexes II-III, III and IV by up to 40%. We also observed that trolox (alpha-tocopherol) and creatine totally prevented the inhibitory effects provoked by the BCAA on the respiratory chain complex activities, suggesting that free radicals were involved in these effects. The results indicate that the major metabolites accumulating in MSUD disturb brain aerobic metabolism by compromising the citric acid cycle and the electron flow through the respiratory chain. We presume that these findings may be of relevance to the understanding of the pathophysiology of the neurological dysfunction of MSUD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680360     DOI: 10.1007/s11064-007-9423-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

1.  Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria.

Authors:  R E TASHIAN
Journal:  Metabolism       Date:  1961-05       Impact factor: 8.694

Review 2.  Neuroenergetics: calling upon astrocytes to satisfy hungry neurons.

Authors:  Luc Pellerin; Pierre J Magistretti
Journal:  Neuroscientist       Date:  2004-02       Impact factor: 7.519

3.  Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain.

Authors:  H R Zielke; Y Huang; P J Baab; R M Collins; C L Zielke; J T Tildon
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

Review 4.  Lipid peroxidation in mitochondria.

Authors:  A Bindoli
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

5.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria.

Authors:  M A Birch-Machin; H L Briggs; A A Saborido; L A Bindoff; D M Turnbull
Journal:  Biochem Med Metab Biol       Date:  1994-02

7.  Effects of branched chain alpha-ketoacids on the metabolism of isolated rat liver cells. III. Interactions with pyruvate dehydrogenase.

Authors:  E Walajtys-Rode; J R Williamson
Journal:  J Biol Chem       Date:  1980-01-25       Impact factor: 5.157

8.  Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.

Authors:  S R Felber; W Sperl; A Chemelli; C Murr; U Wendel
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

9.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

10.  Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy.

Authors:  Anitsi Loaiza; Omar H Porras; Luis Felipe Barros
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

View more
  28 in total

1.  Phenylbutyrate therapy for maple syrup urine disease.

Authors:  Nicola Brunetti-Pierri; Brendan Lanpher; Ayelet Erez; Elitsa A Ananieva; Mohammad Islam; Juan C Marini; Qin Sun; Chunli Yu; Madhuri Hegde; Jun Li; R Max Wynn; David T Chuang; Susan Hutson; Brendan Lee
Journal:  Hum Mol Genet       Date:  2010-11-23       Impact factor: 6.150

2.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

3.  Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.

Authors:  Caroline Paula Mescka; Gilian Guerreiro; Bruna Donida; Desirèe Marchetti; Carlos Alberto Yasin Wayhs; Graziela Schimitt Ribas; Adriana Simon Coitinho; Moacir Wajner; Carlos Severo Dutra-Filho; Carmen Regla Vargas
Journal:  Metab Brain Dis       Date:  2015-05-24       Impact factor: 3.584

4.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

5.  The intra-hippocampal leucine administration impairs memory consolidation and LTP generation in rats.

Authors:  Viviane Glaser; Valeria P Carlini; Laura Gabach; Marisa Ghersi; Susana Rubiales de Barioglio; Oscar A Ramirez; Mariela F Perez; Alexandra Latini
Journal:  Cell Mol Neurobiol       Date:  2010-06-26       Impact factor: 5.046

6.  Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.

Authors:  Luciana Rosa; Leticia S Galant; Dhébora M Dall'Igna; Janaina Kolling; Cassiana Siebert; Patrícia F Schuck; Gustavo C Ferreira; Angela T S Wyse; Felipe Dal-Pizzol; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

7.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

9.  Sensory-motor polyneuropathy occurring in variant maple syrup urine disease.

Authors:  S Harty; M D King; B McCoy; D Costigan; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2008-10-16       Impact factor: 4.982

10.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.